News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,696 Results
Type
Article (88447)
Company Profile (813)
Press Release (788406)
Multimedia
Podcasts (222)
Webinars (34)
Section
Business (233443)
Career Advice (4155)
Deals (39929)
Drug Delivery (170)
Drug Development (91566)
Employer Resources (207)
FDA (18491)
Job Trends (17461)
News (398387)
Policy (40011)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (178)
Alliances (56986)
ALS (211)
Alzheimer's disease (1901)
Antibody-drug conjugate (ADC) (460)
Approvals (18746)
Artificial intelligence (765)
Autoimmune disease (265)
Automation (56)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (226)
Biotechnology (486)
Bladder cancer (190)
Brain cancer (77)
Breast cancer (747)
Cancer (5871)
Cardiovascular disease (514)
Career advice (3585)
Career pathing (48)
CAR-T (338)
CDC (73)
Celiac Disease (2)
Cell therapy (933)
Cervical cancer (45)
Clinical research (78050)
Collaboration (2177)
Company closure (7)
Compensation (1356)
Complete response letters (96)
COVID-19 (3020)
CRISPR (112)
C-suite (1108)
Cystic fibrosis (161)
Data (7500)
Decentralized trials (3)
Denatured (83)
Depression (179)
Dermatology (72)
Diabetes (601)
Diagnostics (7451)
Digital health (60)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (382)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (288)
Earnings (101419)
Editorial (73)
Employer branding (25)
Employer resources (174)
Events (136831)
Executive appointments (1130)
FDA (22174)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1785)
Gene editing (242)
Generative AI (85)
Gene therapy (766)
GLP-1 (1222)
Government (5523)
Grass and pollen (8)
Guidances (405)
Healthcare (21058)
HIV (84)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (333)
Immuno-oncology (97)
Indications (165)
Infectious disease (3385)
Inflammatory bowel disease (225)
Inflation Reduction Act (17)
Influenza (143)
Intellectual property (288)
Interviews (817)
IPO (17979)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (20)
Labor market (107)
Layoffs (672)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (31)
Lung cancer (783)
Lymphoma (422)
Machine learning (57)
Management (66)
Manufacturing (1061)
MASH (196)
Medical device (15177)
Medtech (15265)
Mergers & acquisitions (23151)
Metabolic disorders (1621)
mRNA (225)
Multiple sclerosis (188)
NASH (24)
Neurodegenerative disease (443)
Neuropsychiatric disorders (117)
Neuroscience (3471)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (793)
Opinion (360)
Ovarian cancer (203)
Pain (261)
Pancreatic cancer (281)
Parkinson's disease (376)
Partnered (39)
Patents (596)
Patient recruitment (651)
Peanut (65)
People (67544)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24112)
Phase 2 (33884)
Phase 3 (25496)
Pipeline (7712)
Policy (378)
Postmarket research (3556)
Preclinical (10844)
Press Release (72)
Prostate cancer (299)
Psychedelics (62)
Radiopharmaceuticals (342)
Rare diseases (1133)
Real estate (7449)
Recruiting (81)
Regulatory (29804)
Reports (75)
Research institute (2759)
Resumes & cover letters (653)
Rett syndrome (35)
RNA editing (24)
RSV (98)
Schizophrenia (182)
Series A (297)
Series B (219)
Service/supplier (30)
Sickle cell disease (116)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (53)
Startups (4351)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (136)
Vaccines (1244)
Venture capital (113)
Weight loss (545)
Women's health (121)
Worklife (24)
Date
Today (114)
Last 7 days (723)
Last 30 days (2671)
Last 365 days (33034)
2026 (10027)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58723)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (378)
Arkansas (16)
Asia (51950)
Australia (9131)
California (13055)
Canada (3706)
China (1377)
Colorado (565)
Connecticut (578)
Delaware (397)
Europe (119643)
Florida (1944)
Georgia (428)
Hawaii (4)
Idaho (69)
Illinois (1124)
India (94)
Indiana (615)
Iowa (24)
Japan (526)
Kansas (138)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1608)
Massachusetts (9556)
Michigan (396)
Minnesota (738)
Mississippi (7)
Missouri (158)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (91)
New Jersey (3508)
New Mexico (33)
New York (3454)
North Carolina (1775)
North Dakota (10)
Northern California (6380)
Ohio (404)
Oklahoma (26)
Oregon (55)
Pennsylvania (2609)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (84)
South Dakota (2)
Southern California (5097)
Tennessee (208)
Texas (2107)
United States (46984)
Utah (394)
Vermont (1)
Virginia (331)
Washington D.C. (88)
Washington State (1081)
West Virginia (4)
Wisconsin (147)
Wyoming (2)
There are 877,696 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Policy
FDA Policy Tracker 2026: Psychedelics get a boost
A year of significant policy change at the FDA brought momentum and scrutiny into the new year. As 2026 gets underway, biopharma companies are responding to sweeping vaccine changes while concerns surface about the politicization of the agency.
April 20, 2026
·
10 min read
·
BioSpace Editorial Staff
Layoff Tracker
BMS layoffs hits Lawrenceville hard, adding 200+ to cut count
Follow along as
BioSpace
tracks job cuts and restructuring initiatives.
April 20, 2026
·
49 min read
·
BioSpace Editorial Staff
Lung cancer
Merck’s early PD-1/VEGF data competitive in lung cancer, but Summit ‘Looms Large’
While Merck’s PD-1/VEGF asset appears to match the performance of Summit Therapeutics’ ivonescimab, the pharma’s Phase 1/2 readout in non-small cell lung cancer still leaves analysts with some questions moving into later-stage development.
April 20, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
UCB elevates epilepsy expertise with up to $1.15B Neurona takeover
The acquisition of Neurona will put UCB in both the epilepsy and cell therapy space, even as many of its fellow pharmas move away from the latter modality.
April 20, 2026
·
2 min read
·
Tristan Manalac
Psychedelics
Trump throws support behind psychedelics with executive order
A new executive order could usher in psychedelics as the “key next wave” of mental health therapies, according to analysts at RBC Capital Markets.
April 20, 2026
·
2 min read
·
Tristan Manalac
Press Releases
FDA Grants Priority Review for KEYTRUDA® (pembrolizumab) and KEYTRUDA QLEX™ (pembrolizumab and berahyaluronidase alfa-pmph), Each with Padcev® (enfortumab vedotin-ejfv), for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer
April 20, 2026
·
19 min read
Press Releases
Asahi Kasei Announces Initiation of Phase I Clinical Trial for Novel Peptide Candidate Targeting Autoimmune Diseases
April 20, 2026
·
2 min read
Press Releases
United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
April 20, 2026
·
6 min read
Press Releases
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
April 20, 2026
·
5 min read
Press Releases
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
April 20, 2026
·
7 min read
1 of 87,770
Next
